1814918-91-6
1814918-91-6
Chemical Structure
Soralimixin
Synonym(s): BRII-693; QPX9003
- CAS No.: 1814918-91-6
- Formula:C48H80Cl2N16O13
- Molecular Weight:1160.15
InChIKey: XRXBRIQKVLXFMJ-BCLXPCSMSA-N
SMILES: O=C(N[C@H](C(N[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@](C(NCC1)=O)([H])[C@H](O)C)=O)CCN)=O)CCN)=O)CC)=O)CC(C)C)=O)CCN)[C@H]1NC([C@H](CN)NC([C@H]([C@H](O)C)NC([C@H](CCN)NC(C2=C(C=C(C=C2)Cl)Cl)=O)=O)=O)=O
Biological Activity: Soralimixin (BRII-693), a Polymyxin derivative, is a next-generation intravenous (IV)-administered synthetic macrocyclic peptide antibiotic. Soralimixin can be used for the study of infections caused by drug-resistant Gram-negative pathogens[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Soralimixin | Soralimixin (BRII-693), a Polymyxin derivative, is a next-generation intravenous (IV)-administered synthetic macrocyclic peptide antibiotic. Soralimixin can be used for the study of infections caused by drug-resistant Gram-negative pathogens. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
